OmniAb (OABI) EBITDA Margin (2022 - 2026)
OmniAb's EBITDA Margin came in at -21.89% for Q2 2026, up 192.17 percentage points from -214.06% a year earlier but down 13.61 percentage points from the prior quarter.
Powered by 
Analysis
OmniAb (OABI) EBITDA Margin (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, OmniAb reported EBITDA Margin of -66.77%, up 117.04 percentage points year-over-year; for FY2025, it came in at -252.95%, down 60.01 percentage points from FY2024.
- EBITDA Margin has declined in each of the last three years, with a four-year change of -197.24 percentage points (FY2021 to FY2025).
- Going back by year, EBITDA Margin was -192.94% in FY2024 (-46.82 pp), -146.12% in FY2023 (-131.91 pp), -14.22% in FY2022 (+41.49 pp) and -55.71% in FY2021.
- The five-year range for quarterly EBITDA Margin is -602.28% (Q3 2025) to 39.24% (Q4 2022).
- Year-over-year, EBITDA Margin increased in four of the last eight quarters, with an average year-over-year change of +61.05 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2024 (a gain of 260.87 percentage points), and the weakest in Q1 2024 (a drop of 441.90 percentage points).
- Business Quant data shows OABI's EBITDA Margin at -8.28% (Q1 2026), -96.22% (Q4 2025) and -602.28% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | OmniAb | 689.15 Mn | 474.56 Mn | 12.81 Mn | -21.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.89% |
| Mar 31, 2026 | -8.28% |
| Dec 31, 2025 | -96.22% |
| Sep 30, 2025 | -602.28% |
| Jun 30, 2025 | -214.06% |
| Mar 31, 2025 | -261.75% |
| Dec 31, 2024 | -76.58% |
| Sep 30, 2024 | -355.63% |
| Jun 30, 2024 | -134.02% |
| Mar 31, 2024 | -463.14% |
| Dec 31, 2023 | -337.45% |
| Sep 30, 2023 | -282.47% |
| Jun 30, 2023 | -209.98% |
| Mar 31, 2023 | -21.24% |
| Dec 31, 2022 | 39.24% |
| Sep 30, 2022 | -150.61% |
| Jun 30, 2022 | -112.20% |
| Mar 31, 2022 | -39.33% |
API Access
OmniAb EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OABI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "OABI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OABI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();